Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GAMIDA CELL LTD.

(GMDA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about GAMIDA CELL LTD.
01/19Gamida Cell Plans Rolling Submission of Biologics License Application for Bone Marrow T..
MT
01/19Gamida Cell to Begin Biologics License Application Submission for Omidubicel
DJ
01/19GAMIDA CELL : Provides Update on Omidubicel BLA Submission - Form 8-K
PU
01/19Gamida Cell Provides Update on Omidubicel BLA Submission
BU
01/19Gamida Cell Provides Update on Omidubicel BLA Submission
CI
01/13GAMIDA CELL : Amendment to Initial Statement of Beneficial Ownership (Form 3/A)
PU
01/07Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy M..
BU
2021Gamida Cell Presents Two-Year Survival Data for GDA-201 and Resource Utilization Analys..
BU
2021Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual Meeting
BU
2021Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual Meeting
CI
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors Gamida C..
PR
2021Gamida Cell Ltd. Announces Resignation of David Fox from the Board of Directors
CI
2021Needham Adjusts Price Target on Gamida Cell to $12 from $14, Keeps Buy Rating
MT
2021Oppenheimer Adjusts Gamida Cell PT to $15 From $17, Maintains Outperform Rating
MT
2021Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
BU
More most relevant news
All news about GAMIDA CELL LTD.
01/19Gamida Cell Plans Rolling Submission of Biologics License Application for Bone Marrow T..
MT
01/19Gamida Cell to Begin Biologics License Application Submission for Omidubicel
DJ
01/19GAMIDA CELL : Provides Update on Omidubicel BLA Submission - Form 8-K
PU
01/19Gamida Cell Provides Update on Omidubicel BLA Submission
BU
01/19GAMIDA CELL LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/19Gamida Cell Provides Update on Omidubicel BLA Submission
CI
01/13GAMIDA CELL : Amendment to Initial Statement of Beneficial Ownership (Form 3/A)
PU
01/07Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy M..
BU
01/03GAMIDA CELL LTD. : Regulation FD Disclosure (form 8-K)
AQ
2021AML Hub increases congress coverage to provide latest developments in acute myeloid leu..
AQ
More news
News in other languages on GAMIDA CELL LTD.
01/19Gamida Cell prévoit de soumettre une demande de licence de produits biologiques pour un..
01/19Gamida Cell fait le point sur la soumission de l'Omidubicel BLA
2021Gamida Cell creuse sa perte au premier trimestre
2021Gamida Cell creuse sa perte nette pour l'année 2020 et publie ses prévisions pour 2021
2021Gamida Cell s'envole de 24 % après que l'étude de phase 3 ciblant les hémopathies malig..
2020Gamida Cell sera ajouté à l'indice biotechnologique du NASDAQ avant l'ouverture du marc..
2020Gamida Cell lance un placement de 8,125 millions d'euros à 8 dollars par action
2020Gamida Cell prépare une offre publique de vente subséquente
2020MISE À JOUR SECTORIELLE : Les actions du secteur de la santé sont mitigées lundi avant le ..
2020MISE À JOUR SECTORIELLE : Soins de santé
More news
Analyst Recommendations on GAMIDA CELL LTD.
2021Needham Adjusts Price Target on Gamida Cell to $12 from $14, Keeps Buy Rating
MT
2021Oppenheimer Adjusts Gamida Cell PT to $15 From $17, Maintains Outperform Rating
MT
2021RBC Cuts Price Target on Gamida Cell to $11 From $14, Citing Setback to Omidubicel Fili..
MT
2021GAMIDA CELL : RBC Capital Adjusts Gamida Cell PT to $14 From $12, Maintains Outperform - S..
MT
2021GAMIDA CELL : Needham Adjusts Price Target on Gamida Cell to $14 From $17, Maintains Buy R..
MT
More recommendations
Press releases
01/19GAMIDA CELL : Provides Update on Omidubicel BLA Submission - Form 8-K
PU
01/19Gamida Cell Provides Update on Omidubicel BLA Submission
BU
01/19GAMIDA CELL LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/13GAMIDA CELL : Amendment to Initial Statement of Beneficial Ownership (Form 3/A)
PU
01/07Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy M..
BU
More press releases
Upcoming event on GAMIDA CELL LTD.